FibroGen Inc FGEN:NASDAQ

Last Price$8.41NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-0.79(8.59%)
Bid (Size)$7.00 (1)
Ask (Size)$15.80 (20)
Day Low / High$8.22 - 9.11
Volume853.6 K
 

View Biotechnology IndustryPeer Comparison as of 05/18/2022

 

FibroGen Inc ( NASDAQ )

Price: $8.41
Change: -0.79 (8.59%)
Volume: 853.6 K
4:00PM ET 5/18/2022
 
 

ImmunoGen Inc ( NASDAQ )

Price: $3.51
Change: -0.45 (11.27%)
Volume: 4.6 M
4:00PM ET 5/18/2022
 
 

Cassava Sciences Inc ( NASDAQ )

Price: $22.28
Change: -0.48 (2.11%)
Volume: 103.00
4:00PM ET 5/18/2022
 
 

Editas Medicine Inc ( NASDAQ )

Price: $10.72
Change: -0.91 (7.82%)
Volume: 6.00
4:00PM ET 5/18/2022
 
 

Regenxbio Inc ( NASDAQ )

Price: $19.57
Change: -2.13 (9.82%)
Volume: 501.6 K
4:00PM ET 5/18/2022
 

Read more news Recent News

Top Midday Gainers
1:32PM ET 5/10/2022 MT Newswires

Biohaven Pharmaceutical (BHVN) surged past 70% after Pfizer (PFE) agreed to acquire Biohaven's remaining shares that it didn't already own for $11.6...

FibroGen Q1 Loss Narrows, Revenue Rises
4:17PM ET 5/09/2022 MT Newswires

FibroGen (FGEN) reported late Monday a Q1 loss of $0.68 per diluted share, compared with a loss of $0.78 a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (FGEN) FIBROGEN Reports Q1 Revenue $60.8M, vs. Street Est of $28.8M
4:14PM ET 5/09/2022 MT Newswires

...

-- Earnings Flash (FGEN) FIBROGEN Reports Q1 Loss $-0.68, vs. Street Est of $-0.92
4:13PM ET 5/09/2022 MT Newswires

...

Company Profile

Business DescriptionFibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA. View company web site for more details
Address409 Illinois Street
San Francisco, California 94158-2509
Phone+1.415.978.1200
Number of Employees461
Recent SEC Filing05/09/202210-Q
Chief Executive Officer & DirectorEnrique A. Conterno
Chief Financial Officer & Senior Vice PresidentJuan Graham
Senior Vice President-Technical DevelopmentMichael Martinelli
Senior VP-Clinical Development & Drug SafetyElias Kouchakji

Company Highlights

Price Open$8.93
Previous Close$8.41
52 Week Range$7.81 - 30.12
Market Capitalization$784.6 M
Shares Outstanding93.3 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.04
Beta vs. S&P 500N/A
Revenue$213.0 M
Net Profit Margin-109.22%
Return on Equity-118.07%

Analyst Ratings as of 03/01/2022

Buy
0
Overweight
0
Hold
6
Underweight
0
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset